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Studies of circulatory disease deaths among workers with high occupational exposures to arsenic generally have shown either no or weak associations. Among the Anaconda, Montana, smelter workers, Lubin et al. (5) found a small but significant elevation in the standardized mortality ratios (SMR) for all circulatory disease (SMR = 109) but no consistent pattern by duration of employment. Among the Ronnskar, Sweden, smelter workers (6) , there is a slight suggestion of increasing mortality from ischemic heart disease as cumulative exposure rises, but mortality falls off at the highest exposure level. In earlier analyses of the Swedish smelter workers, Axelson et al. (7) observed a statistically significant excess of cardiovascular disease and a clear dose response with increasing exposure levels. The third major cohort of smelter workers exposed to arsenic has been investigated extensively for associations with respiratory cancer but not circulatory disease (8, 9) , although the earlier report listed standardized mortality ratios for stroke (SMR = 111.4) and heart disease (SMR = 92.5).
On the one hand, the weaker evidence from occupational studies as opposed to community drinking water studies could stem from the difference in route of exposure (inhalation vs. ingestion). On the other, circulatory disease mortality usually is reduced in occupational cohorts relative to that in the general population as a result of the healthy worker effect. This effect can be dramatic, with reductions of sometimes more than 50 percent, especially in the first few years after workers are hired. Given a worker's background of superior cardiovascular health, any adverse effects due to occupational exposures could easily be missed. That the occupational studies are inconsistent with respect to arsenic's atherogenicity is therefore not surprising, as others have pointed out (4, 10) . To elucidate the relation between arsenic and circulatory disease mor-tality in an occupationally exposed cohort, we conducted analyses of smelter workers by using a variety of methods to control for the healthy worker effect, including both the initial healthy hire effect and the subsequent healthy worker survivor effect (HWSE).
MATERIALS AND METHODS

Database
Study subjects for this investigation comprised a cohort of 2,802 White males employed 1 year or more during 1940-1964 at a single copper smelter in Tacoma (8, 9) . Air arsenic data were taken from spot and tape samples before 1971 and then from personal samplers starting in 1971. When air measurements were not available, urinary arsenic data were converted to air estimates by using the mathematical relation (between arithmetic mean air arsenic and geometric mean urinary arsenic levels) determined for the years and departments in which both types of measurements were available. Cumulative air arsenic exposure for each person-year of follow-up was based on summing exposures from the start of employment or from 1940 (for those employed earlier) to the year of follow-up under analysis.
Statistical analysis
Because the prevalence of circulatory disease among employed persons is lower than in the general population, any occupational study of this outcome must control for the healthy worker effect. This effect is comprised of several selection processes, including the healthy hire effect, the HWSE, and the time-sincehire effect. The first involves entry into employment of healthier persons; the second, selection out of employment of the less healthy among those hired; and the third, declining health status with time since initial selection into the workforce. Each produces a bias, but the methods for control differ. It is possible to adjust for initial, nonrandom selection into the workforce through the use of internal controls; that is, instead of mortality of an occupational cohort being compared with that of the general population, mortality of an exposed group is compared with that of an unexposed or minimally exposed group within the cohort. We therefore made internal comparisons by applying Poisson regression modeling. These models were fit with control of age and year of hire. Because of a cohort effect, year of hire was an important risk factor to control. Time-since-hire can be controlled in a number of different ways. In previous work, two of the authors (H. A. and I. H-P.) showed that when age and other time-related work variables are included, further adjustment for time-since-hire has little impact on estimates of exposure effects (11) . As is typical of occupational cohort studies, data on other individual risk factors were not collected. We controlled for current age because of its strong association with mortality from cardiovascular disease.
Control for the HWSE is the most difficult. Several methods have been proposed and have been reviewed and critiqued previously (12, 13) . One method considers the HWSE to be a form of selection bias, two methods treat it as a confounder, and the last characterizes it as both a confounder and an intermediate variable.
We applied these methods as follows:
1. The restriction method (14) involves removing all employees with fewer than a selected number of years of follow-up. Because this method is flawed (12, 13), we did not include it. 2. The lagging method (15) , rather than restricting the persons, restricts the exposures to be considered. Since the most recent exposures were incurred by survivors only (those who do not leave employment), they are discounted and only earlier exposures are counted. We used lagging periods of 10, 15, and 20 years. 3. Adjustment for employment status as a timedependent variable in each year of follow-up treats job leaving as a confounder, since it is generally related to both exposure (enabling future exposure or not) and outcome (when the lesshealthy leave work) (16, 17) . This method can also be combined with lagging of exposure. We implemented the work status adjustment with two indicator variables: one for persons not at work and less than 60 years of age, the other for those not at work and aged 60 years or older.
For methods 2 and 3, all analyses are compared with a baseline regression model in which age and year of hire are covariates but the HWSE is not controlled. Because there were no unexposed workers in this cohort, rate ratios for each exposure level were calculated in comparison with the lowest exposure category, which represented person-years in which the cumulative arsenic exposure was <750 |Xg/m 3 -years.
4. The fourth method differs fundamentally from the others, in that it recognizes the intermediate nature of survivorship on the job. Robins (18) has shown that the conditions for confounding by time-dependent variables differ from the nontime-dependent situation and that if earlier exposures are associated with subsequent covariate status, then ordinary methods of analysis for time-dependent variables are biased. Job leaving is not only related to past health status and exposure, it is also in part a determinant of subsequent exposure.
A very simple example of this approach is as follows: Consider the hypothetical data in table 2. A total of 2,000 workers are hired at t = 0 (tO), half at low and half at high exposure, assigned randomly. At t = 1 (tl), each group experiences some attrition: 50 percent of the high-exposure group and 10 percent of the lowexposure group leave work. By t = 2 (t2), there have been 250 deaths in the high-exposure group and 210 deaths in the low-exposure group, for a crude (intentto-treat) relative risk of 1.19 or a matched-pairs odds ratio of 1.25. However, when the information is stratified by work status, the relative risk is 1.0, since mor- Probabilities (in parentheses) and numbers of deaths at time t Using the McNemar matched-pair odds ratio, concordant case-control pairs are ignored. By pairing each case with each control, the number of discordant pairs with cases at high exposure is 250 x 790 and the number of discordant pairs with cases at low exposure is 210 x 750, resulting in an odds ratio of 1.25.
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The stratified analysis is incorrect, however, because the job leaving at tl is not random; therefore, workers with a high-exposure job who leave work are not comparable to those with a low-exposure job who leave work. The latter group of job leavers is at higher risk: only those with the poorest underlying health leave work from a low-exposure job, while workers who leave the high-exposure job include some with moderate or good underlying health. As a corollary, the 500 at work at tl who were assigned high exposure at tO are not comparable to the 900 at tl who were originally assigned low exposure. Up to this point, the G-estimate is based on the same contrast as the intent-to-treat estimate, although it is calculated as the matched-pairs odds ratio. However, with further follow-up and further random reassignments of exposure, these two will deviate. Note also that the lagged exposure gives the same relative risk as an intent-to-treat analysis, which will no longer be true at t3 (not shown here).
In contrast to the other methods, the G-null test (18) and associated odds ratio do not use cumulative exposure; instead, they focus on the exposure rate for the relevant time period. Cases are matched with surviving members of the cohort who have a similar exposure and employment history in all prior years; to calculate odds ratios for differing levels of exposure, analysis proceeds by examining exposure differences at points at which cases and their matched controls diverge. The bottom portion of table 2 shows the matched pairs that are obtained from using the scenario in the top portion. In this scenario, the exposure of interest is the assigned exposure at time tO, and there are no prior exposures on which we must match. Cases are reused, as are controls, even at this one time point; thus, the number of distinct pairs in a cell of the matched-pairs 2x2 table is the product of the number of cases and the number of controls. A modified form (18) of this analysis loosens the matching criteria so that an exact match need be only for the exposure pattern of a few consecutive years rather than from the start of follow-up. Our analyses of the arsenic-exposed cohort are presented with no lag and with 10-, 15-, and 20-year lags. Cases and controls were matched on age and on date of hire.
RESULTS
The numbers of person-years of follow-up and of circulatory disease deaths by each category of cumulative arsenic exposure are shown in table 1. Tables 3 and 4 present the results of Poisson regression models without adjustment for the HWSE (the baseline model) and with the lagging and work status adjustments. The baseline model showed a dip in the first few exposure levels above the lowest, whether one looked at total circulatory disease (table 3) or cardiovascular disease (table 4) mortality; rate ratios for cardiovascular deaths then rose slightly above 1.0 at the higher cumulative exposure levels. This appears to resemble the checkmark dose response discussed by Flanders et al. (19) . These authors demonstrated that such a pattern can result if disease influences exposure, an observation consistent with the conceptualization of job survivorship as simultaneously a confounder and an intermediate variable.
The use of lagged exposures increased the mortality rate ratios for circulatory and cardiovascular disease at all levels of exposure as compared with the baseline model. The dose-response curve was steepest at low cumulative exposures, with a flattening or even a slight decline for the highest exposure category. Furthermore, arsenic seemed to have its strongest effects on cardiovascular disease deaths, since almost all of the rate ratios were higher for cardiovascular than for total circulatory disease mortality. Adjustment for employment status with two indicator variables for those not employed at the plant and less than 60 years of age and those not employed at the plant and aged 60 years or older also resulted in increased rate ratios for all exposure categories. There was a suggestion of a dose response, although the checkmark pattern was observed for cardiovascular disease. Again, most of the rate ratios were higher for cardiovascular than for total circulatory disease mortality.
Finally, the analyses in which both lagging and adjustment for work status were used snowed an increase in most rate ratios when compared with the models adjusted for work status only. Additional control for work status slightly increased the rate ratios in the model with 10-year lag periods but slightly decreased the rate ratios in the models with a 20-year lag for cardiovascular disease. Regardless of the length of the lagging period or whether adjustment was made for work status, lagging, or both, the excess mortality from cardiovascular disease was 50-100 percent (rate ratios, 1.5-2.0) for the two highest cumulative exposure categories.
G-null analyses of circulatory disease mortality suggested no adverse effect of exposure; all odds ratios in unlagged analyses fell below 1.0 (table 5) . Lagging exposure by 15 years produced slightly elevated odds ratios, but lagging for 10 or 20 years did not. Analyses that required an exposure history to match for only 5 years (modified G-null analyses) rather than for the full period of employment produced similar results (table 5) . Rate ratios were reduced for cerebrovascular mortality at the higher exposure levels (table 6). Adjustment using the employment status covariate and lagged exposure indicated that all of the excess circulatory disease mortality was limited to cardiovascular disease. There were too few events to enable peripheral vascular disease to be evaluated separately.
DISCUSSION
The findings from our analysis, while not conclusive, suggest that the presence of the HWSE may be obscuring an association between arsenic exposure and circulatory disease mortality, particularly cardiovascular disease. Of the three methods used to control this bias, lagging and adjustment for work status yielded positive results; the G-null method yielded negative results. The G-null method, while theoretically the most rigorous, was difficult to apply in this cohort because of the lack of an exact match on exposure history for most of the time points of most cases. In other words, very little of the data was actually usable in this analysis, as predicted by Robins (18) . Further analyses using the more flexible semiparametric extensions of this method-G-estimation (20)-should prove illuminating. One of the authors (I. H-R) recently received funding to apply G-estimation to these and other occupational cohort data.
Both lagging and adjustment for work status suggested dose-response associations between cumulative arsenic exposure and risk of death from circulatory disease. For cardiovascular disease, the suggestion of a dose response was even stronger. Since both of these methods are based on the view that the bias from the HWSE is essentially a problem of confounding, it would appear that the confounding produced by nonrandom job leaving was at least partially controlled.
Thus, to the extent that the HWSE acts as a confounder, adjustment by lagging the exposure or by using employment status as a time-dependent covariate controls the bias produced by differential job leaving, in which unhealthy workers are more likely to terminate employment and the healthier ones remain to accumulate higher exposures. Lagging exposure is also commonly used in occupational studies to account for a latency period between the time of exposure and the death associated with that exposure. In our use of lagging, it was assumed that the latency period was longer than the period during which exposures influenced job leaving. The fact that the rate ratios for cardiovascular disease were generally highest for about a 10-year lag suggests that the impact of exposures on this outcome is manifest 10 or more years later and that the HWSE in relation to a given year of exposures could last as long as 10 years.
Although the rate ratios appear to be small, the high proportion of total mortality due to circulatory disease (-50 percent) or even cardiovascular disease (-35 percent) in the United States and other western countries places a natural limit on the magnitude of these ratios. Also, since circulatory disease has multiple risk factors, any single contributing factor is likely to account for a small proportion of the disease burden. Nevertheless, small increases in rate ratios translate into large numbers of excess deaths.
Supporting evidence regarding a possible effect of arsenic on the circulatory system comes from toxicology experiments in animals, ingestion studies in humans, and occupational mortality investigations. A number of experiments in animals suggest that arsenic, either in its trivalent or pentavalent form, affects vascular responsiveness (21) (22) (23) .
With regard to human exposures, peripheral vascular lesions have historically been documented in numerous regions in which the drinking water has a high arsenic content, including Chile, Poland, A series of studies in this same region of Taiwan, including an ecologic, a cohort, and a case-control study, have shown significantly elevated rates of ischemic heart disease mortality and prevalence in association with arsenic exposure (4, 27) . Moreover, Wu et al. (3) observed excesses of cardiovascular but not cerebrovascular mortality, with clear doseresponse relations based on arsenic levels in drinking water.
Occupational exposures to arsenic involve primarily inhalation rather than ingestion. As described earlier, standard analyses of the Anaconda, Montana, and Ronnskar, Sweden, cohorts of smelter workers provided weak evidence of an effect on circulatory disease, whereas an earlier analysis of the Tacoma, Washington, cohort showed a slight deficit in heart disease mortality (SMR = 92.5) (8) . Similarly, our baseline model of this cohort did not reveal any association; only after adjustment for the HWSE by lagging, adjustment for work status, or both, did any elevation in circulatory disease mortality become evident. Many of the previous reports for all three cohorts did not attempt to control for the healthy worker effect, particularly the survivor effect, in any way. Any elevation in circulatory disease mortality is unusual for an occupational cohort.
Thus, on the basis of prior evidence from animal experiments and from ingestion studies of populations exposed via drinking water, an association between occupational arsenic exposure and increased circulatory disease mortality is plausible. The current investigation appears to provide further evidence for such an association, including the rise in risk with increasing exposure to arsenic. While confounding from smoking is possible, the prevalence of smoking varies relatively little across job categories within a plant (in contrast to the wide variations across occupations and industries in the general population), so that use of internal comparisons and analysis of dose response frequently precludes such confounding. In the Ronnskar smelter, a nested case-control study reported stronger associations with lung cancer at the higher exposure groups after adjustment for smoking than before, suggesting negative, not positive, confounding across exposure levels (6) . In a population-based case-control study of lung and bladder cancers in Montreal, Canada, an index of job dirtiness based on lifetime occupational histories did not correlate with smoking history (28) . Additionally, adjustment for age and year of hire (to control a cohort effect) reduced the likelihood that our elevated rate ratios were due to confounding from lifestyle factors. Nevertheless, the possibility of such confounding cannot be excluded.
The specificity of finding for cardiovascular but not cerebrovascular mortality is in accord with the results of Wu et al. (3) for a population exposed via ingestion of arsenic in drinking water and those of Axelson et al. (7) for the other well-studied smelter-exposed population. In contrast, Chiou et al. (29) found a doseresponse association between ingested arsenic and the prevalence of cerebrovascular disease in a Taiwanese population outside the blackfoot disease endemic area. Furthermore, a study of the Anaconda smelter workers (30) found a statistically significant excess of cerebrovascular disease mortality.
Does arsenic exposure increase the risk for circulatory disease? In our data, cardiovascular but not cerebrovascular disease death rates were elevated in association with arsenic exposures. Given how common cardiovascular causes of death are in the population, detection of small rate ratios is difficult; this problem is exacerbated when hazardous exposures are evaluated in an occupational setting, because workers are in better health than the general population and because their underlying health status is related to their continuing employment status and hence their exposure. Yet rate ratios of 1.2 and 1.3 for such events translate into far more deaths than do rate ratios of 3 and 4 for respiratory cancer. In fact, rate ratios for even well-established risk factors for cardiovascular disease mortality are small, because cardiovascular disease accounts for such a large proportion of total mortality and is multifactorial. Thus, the public health significance of these findings could be large. As the US Environmental Protection Agency prepares its reappraisal of the drinking water standard, cardiovascular effects need to be addressed in the risk assessment. Further studies of the effects of arsenic on cardiovascular disease are needed to define more precisely the dose-response association. Finally, when studies are conducted of arsenic or other agents present in the workplace, both the healthy hire effect and the HWSE strongly influence the risk of cardiovascular events. Therefore, investigations of cardiovascular effects from occupational chemical exposures
